BNP/CALL/CVS HEALTH/100/0.1/16.01.26 Share Price

Warrant

DE000PC25WS2

Market Closed - Boerse Frankfurt Warrants 20:50:29 31/05/2024 BST
0.13 EUR +30.00% Intraday chart for BNP/CALL/CVS HEALTH/100/0.1/16.01.26
1 month-38.10%
3 months-61.76%
Date Price Change
31/05/24 0.13 +30.00%
30/05/24 0.1 +25.00%
29/05/24 0.08 -.--%
28/05/24 0.08 -20.00%
27/05/24 0.1 +11.11%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 08:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC25WS
ISINDE000PC25WS2
Date issued 10/01/2024
Strike 100 $
Maturity 16/01/2026 (594 Days)
Parity 10 : 1
Emission price 0.49
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.56
Lowest since issue 0.059
Spread 0.02
Spread %12.50%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
59.6 USD
Average target price
70.17 USD
Spread / Average Target
+17.73%
Consensus